{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:37Z","timestamp":1791297817549,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/jhg.2013.107","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T02:14:02Z","timestamp":1382580842000},"page":"16-23","source":"Crossref","is-referenced-by-count":74,"title":["Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies"],"prefix":"10.1038","volume":"59","author":[{"given":"Tom","family":"Nolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"BFjhg2013107_CR1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","volume":"1791","author":"A Garg","year":"2009","unstructured":"Garg, A. & Agarwal, A. K. Lipodystrophies: disorders of adipose tissue biology. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1791, 507\u2013513 (2009).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"BFjhg2013107_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","volume":"33","author":"A Garg","year":"2004","unstructured":"Garg, A. & Misra, A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol. Metab. Clin. North Am. 33, 305\u2013331 (2004).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFjhg2013107_CR3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkn251","volume":"62","author":"JE Mallewa","year":"2008","unstructured":"Mallewa, J. E., Wilkins, E., Vilar, J., Mallewa, M., Doran, D., Back, D. et al. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. J. Antimicrob. Chemother. 62, 648\u2013660 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFjhg2013107_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","volume":"36","author":"GS Nagy","year":"2003","unstructured":"Nagy, G. S., Tsiodras, S., Martin, L. D., Avihingsanon, A., Gavrila, A., Hsu, W. C. et al. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin. Clin. Infect. Dis. 36, 795\u2013802 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFjhg2013107_CR5","first-page":"112","volume":"14","author":"P Domingo","year":"2012","unstructured":"Domingo, P., Estrada, V., L\u00f3pez-Aldeguer, J., Villaroya, F. & Mart\u00ednez, E. Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev. 14, 112\u2013123 (2012).","journal-title":"AIDS Rev."},{"key":"BFjhg2013107_CR6","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548\u20132556 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","volume":"7","author":"AK Agarwal","year":"2006","unstructured":"Agarwal, A. K. & Garg, A. Genetic disorders of adipose tissue development, differentiation, and death. Annu. Rev. Genomics Hum. Genet. 7, 175\u2013199 (2006).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"BFjhg2013107_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2012-1140","volume":"97","author":"N Abate","year":"2012","unstructured":"Abate, N. Adipocyte maturation arrest: a determinant of systemic insulin resistance to glucose disposal. J. Clin. Endocrinol. Metab. 97, 760\u2013763 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","volume":"7","author":"ED Rosen","year":"2006","unstructured":"Rosen, E. D. & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885\u2013896 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFjhg2013107_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cdd.2010.100","volume":"18","author":"H Pei","year":"2011","unstructured":"Pei, H., Yao, Y., Yang, Y., Liao, K. & Wu, J. R. Kru\u00a8ppel-like factor KLF9 regulates PPARg transactivation at the middle stage of adipogenesis. Cell Death Differ. 18, 315\u2013327 (2011).","journal-title":"Cell Death Differ."},{"key":"BFjhg2013107_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1051\/jbio\/2011017","volume":"205","author":"AT Bertrand","year":"2011","unstructured":"Bertrand, A. T., Chikhaoui, K., Ben, Yaou R. & Bonne, G. [Laminopathies: one gene, several diseases]. Biol. Aujourdhui 205, 147\u2013162 (2011).","journal-title":"Biol. Aujourdhui"},{"key":"BFjhg2013107_CR12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","volume":"39","author":"L Van Maldergem","year":"2002","unstructured":"Van Maldergem, L., Magr\u00e9, J., Khallouf, T. E., Gedde-Dahl, T. Jr, Del\u00e9pine, M., Trygstad, O. et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J. Med. Genet. 39, 722\u2013733 (2002).","journal-title":"J. Med. Genet."},{"key":"BFjhg2013107_CR13","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","volume":"88","author":"AK Agarwal","year":"2003","unstructured":"Agarwal, A. K., Simha, V., Oral, E. A., Moran, S. A., Gorden, P., O\u2019Rahilly, S. et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 88, 4840\u20134847 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR14","first-page":"503","volume":"83","author":"VC Pardini","year":"1998","unstructured":"Pardini, V. C., Vict\u00f3ria, I. M., Rocha, S. M., Andrade, D. G., Rocha, A. M., Pieroni, F. B. et al. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J. Clin. Endocrinol. Metab. 83, 503\u2013508 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","volume":"52","author":"J Magre","year":"2003","unstructured":"Magre, J., Del\u00e9pine, M., Van Maldergem, L., Robert, J. J., Maassen, J. A., Meier, M. et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 52, 1573\u20131578 (2003).","journal-title":"Diabetes"},{"key":"BFjhg2013107_CR16","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg, A., Wilson, R., Barnes, R., Arioglu, E., Zaidi, Z., Gurakan, F. et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J. Clin. Endocrinol. Metab. 84, 3390\u20133394 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","volume":"31","author":"AK Agarwal","year":"2002","unstructured":"Agarwal, A. K., Arioglu, E., De Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M. et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31, 21\u201323 (2002).","journal-title":"Nat. Genet."},{"key":"BFjhg2013107_CR18","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db12-0004","volume":"61","author":"AR Subauste","year":"2012","unstructured":"Subauste, A. R., Das, A. K., Li, X., Elliott, B. G., Evans, C., El Azzouny, M. et al. Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes 61, 2922\u20132931 (2012).","journal-title":"Diabetes"},{"key":"BFjhg2013107_CR19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","volume":"14","author":"AK Agarwal","year":"2003","unstructured":"Agarwal, A. K. & Garg, A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol. Metab. 14, 214\u2013221 (2003).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFjhg2013107_CR20","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","volume":"88","author":"V Simha","year":"2003","unstructured":"Simha, V. & Garg, A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J. Clin. Endocrinol. Metab. 88, 5433\u20135437 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1194\/jlr.R023754","volume":"53","author":"BR Cartwright","year":"2012","unstructured":"Cartwright, B. R. & Goodman, J. M. Seipin: from human disease to molecular mechanism. J. Lipid Res. 53, 1042\u20131055 (2012).","journal-title":"J. Lipid Res."},{"key":"BFjhg2013107_CR22","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","volume":"57","author":"VA Payne","year":"2008","unstructured":"Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Dalla Nora, E. et al. The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation. Diabetes 57, 2055\u20132060 (2008).","journal-title":"Diabetes"},{"key":"BFjhg2013107_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20121870","volume":"452","author":"W Yang","year":"2013","unstructured":"Yang, W., Thein, S., Guo, X., Xu, F., Venkatesh, B., Sugii, S. et al. Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus. Biochem. J. 452, 37\u201344 (2013).","journal-title":"Biochem. J."},{"key":"BFjhg2013107_CR24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","volume":"93","author":"CA Kim","year":"2008","unstructured":"Kim, C. A., Del\u00e9pine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M. et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 93, 1129\u20131134 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR25","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","volume":"119","author":"YK Hayashi","year":"2009","unstructured":"Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S. et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest. 119, 2623\u20132633 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFjhg2013107_CR26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/labinvest.2009.23","volume":"89","author":"I Mercier","year":"2009","unstructured":"Mercier, I., Jasmin, J. F., Pavlides, S., Minetti, C., Flomenberg, N., Pestell, R. G. et al. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab. Invest. 89, 614\u2013623 (2009).","journal-title":"Lab. Invest."},{"key":"BFjhg2013107_CR27","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","volume":"152A","author":"S Shastry","year":"2010","unstructured":"Shastry, S., Delgado, M. R., Dirik, E., Turkmen, M., Agarwal, A. K. & Garg, A. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am. J. Med. Genet. A. 152A, 2245\u20132253 (2010).","journal-title":"Am. J. Med. Genet. A."},{"key":"BFjhg2013107_CR28","doi-asserted-by":"crossref","first-page":"e1000874","DOI":"10.1371\/journal.pgen.1000874","volume":"6","author":"A Rajab","year":"2010","unstructured":"Rajab, A., Straub, V., McCann, L. J., Seelow, D., Varon, R., Barresi, R. et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 6, e1000874 (2010).","journal-title":"PLoS Genet."},{"key":"BFjhg2013107_CR29","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg, A. Clinical review: Lipodystrophies: genetic and acquired body fat disorders. J. Clin. Endocrinol. Metab. 96, 3313\u20133325 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaad.2006.05.005","volume":"55","author":"E Pope","year":"2006","unstructured":"Pope, E., Janson, A., Khambalia, A. & Feldman, B. Childhood acquired lipodystrophy: a retrospective study. J. Am. Acad. Dermatol. 55, 947\u2013950 (2006).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFjhg2013107_CR31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","volume":"82","author":"A Misra","year":"2003","unstructured":"Misra, A. & Garg, A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 82, 129\u2013146 (2003).","journal-title":"Medicine (Baltimore)"},{"key":"BFjhg2013107_CR32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","volume":"94","author":"DB Savage","year":"2009","unstructured":"Savage, D. B., Semple, R. K., Clatworthy, M. R., Lyons, P. A., Morgan, B. P., Cochran, E. K. et al. Complement abnormalities in acquired lipodystrophy revisited. J. Clin. Endocrinol. Metab. 94, 10\u201316 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","volume":"83","author":"A Misra","year":"2004","unstructured":"Misra, A., Peethambaram, A. & Garg, A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83, 18\u201334 (2004).","journal-title":"Medicine (Baltimore)"},{"key":"BFjhg2013107_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","volume":"7","author":"CG Fiorenza","year":"2011","unstructured":"Fiorenza, C. G., Chou, S. H. & Mantzoros, C. S. Lipodystrophy: pathophysiology and advances in treatment. Nat. Rev. Endocrinol. 7, 137\u2013150 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFjhg2013107_CR35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","volume":"177","author":"PW Mathieson","year":"1993","unstructured":"Mathieson, P. W., W\u00fcrzner, R., Oliveria, D. B., Lachmann, P. J. & Peters, D. K. Complement-mediated adipocyte lysis by nephritic factor sera. J. Exp. Med. 177, 1827\u20131831 (1993).","journal-title":"J. Exp. Med."},{"key":"BFjhg2013107_CR36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1442-200X.2008.02713.x","volume":"50","author":"J Oswiecimska","year":"2008","unstructured":"Oswiecimska, J., Ziora, K., Geisler, G. & Dyduch, A. Acquired partial lipodystrophy in an 11-year-old girl. Pediatr. Int. 50, 714\u2013716 (2008).","journal-title":"Pediatr. Int."},{"key":"BFjhg2013107_CR37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/505885","volume":"79","author":"RA Hegele","year":"2006","unstructured":"Hegele, R. A., Cao, H., Liu, D. M., Costain, G. A., Charlton-Menys, V., Rodger, N. W. et al. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 79, 383\u2013389 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2013107_CR38","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg, A. Acquired and inherited lipodystrophies. N. Engl. J. Med. 350, 1220\u20131234 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg2013107_CR39","first-page":"33","volume":"43","author":"MG Dunnigan","year":"1974","unstructured":"Dunnigan, M. G., Cochrane, M. A., Kelly, A. & Scott, J. W. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q. J. Med. 43, 33\u201348 (1974).","journal-title":"Q. J. Med."},{"key":"BFjhg2013107_CR40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","volume":"23","author":"J Kobberling","year":"1986","unstructured":"Kobberling, J. & Dunnigan, M. G. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J. Med. Genet. 23, 120\u2013127 (1986).","journal-title":"J. Med. Genet."},{"key":"BFjhg2013107_CR41","first-page":"170","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg, A., Peshock, R. M. & Fleckenstein, J. L. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84, 170\u2013174 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR42","first-page":"1776","volume":"85","author":"A Garg","year":"2000","unstructured":"Garg, A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85, 1776\u20131782 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR43","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","volume":"93","author":"MC Vantyghem","year":"2008","unstructured":"Vantyghem, M. C., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S. et al. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 93, 2223\u20132229 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(02)01070-7","volume":"112","author":"A Garg","year":"2002","unstructured":"Garg, A., Speckman, R. A. & Bowcock, A. M. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A\/C gene. Am. J. Med. 112, 549\u2013555 (2002).","journal-title":"Am. J. Med."},{"key":"BFjhg2013107_CR45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0004.2009.01350.x","volume":"78","author":"L Subramanyam","year":"2010","unstructured":"Subramanyam, L., Simha, V. & Garg, A. (2010) Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A\/C mutations. Clin. Genet. 78, 66\u201373.","journal-title":"Clin. Genet."},{"key":"BFjhg2013107_CR46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","volume":"18","author":"JM Peters","year":"1998","unstructured":"Peters, J. M., Barnes, R., Bennett, L., Gitomer, W. M., Bowcock, A. M. & Garg, A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat. Genet. 18, 292\u2013295 (1998).","journal-title":"Nat. Genet."},{"key":"BFjhg2013107_CR47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","volume":"9","author":"H Cao","year":"2000","unstructured":"Cao, H. & Hegele, R. A. Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109\u2013112 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg2013107_CR48","first-page":"408","volume":"87","author":"AK Agarwal","year":"2002","unstructured":"Agarwal, A. K. & Garg, A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 87, 408\u2013411 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/ddi480","volume":"15","author":"RL Boguslavsky","year":"2006","unstructured":"Boguslavsky, R. L., Stewart, C. L. & Worman, H. J. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 15, 653\u2013663 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg2013107_CR50","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","volume":"14","author":"M Caron","year":"2007","unstructured":"Caron, M., Auclair, M., Donadille, B., B\u00e9r\u00e9ziat, V., Guerci, B., Laville, M. et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 14, 1759\u20131767 (2007).","journal-title":"Cell Death Differ."},{"key":"BFjhg2013107_CR51","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C. et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304, 1325\u20131328 (2004).","journal-title":"Science"},{"key":"BFjhg2013107_CR52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","volume":"1","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S. et alLD Screening Consortium Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 1, 280\u2013287 (2009).","journal-title":"EMBO Mol. Med."},{"key":"BFjhg2013107_CR53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","volume":"364","author":"S Gandotra","year":"2011","unstructured":"Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y. et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 364, 740\u2013748 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg2013107_CR54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MOL.0b013e32830dd09b","volume":"19","author":"SO Olofsson","year":"2008","unstructured":"Olofsson, S. O., Bostr\u00f6m, P., Andersson, L., Rutberg, M., Levin, M., Perman, J. et al. Triglyceride containing lipid droplets and lipid droplet-associated proteins. Curr. Opin. Lipidol. 19, 441\u2013447 (2008).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFjhg2013107_CR55","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","volume":"51","author":"RA Hegele","year":"2002","unstructured":"Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T. & Leff, T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51, 3586\u20133590 (2002).","journal-title":"Diabetes"},{"key":"BFjhg2013107_CR56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","volume":"116","author":"RK Semple","year":"2006","unstructured":"Semple, R. K., Chatterjee, V. K. & O\u2019Rahilly, S. PPAR gamma and human metabolic disease. J. Clin. Invest. 116, 581\u2013589 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFjhg2013107_CR57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18632\/aging.100293","volume":"3","author":"P Pichierri","year":"2011","unstructured":"Pichierri, P., Ammazzalorso, F., Bignami, M. & Franchitto, A. The Werner syndrome protein: linking the replication checkpoint response to genome stability. Aging (Albany NY) 3, 311\u2013318 (2011).","journal-title":"Aging (Albany NY)"},{"key":"BFjhg2013107_CR58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3904\/kjim.2009.24.1.68","volume":"24","author":"YJ Doh","year":"2009","unstructured":"Doh, Y. J., Kim, H. K., Jung, E. D., Choi, S. H., Kim, J. G., Kim, B. W. et al. Novel LMNA gene mutation in a patient with Atypical Werner\u2019s Syndrome. Korean J. Intern. Med. 24, 68\u201372 (2009).","journal-title":"Korean J. Intern. Med."},{"key":"BFjhg2013107_CR59","first-page":"52","volume":"70","author":"SG Chun","year":"2011","unstructured":"Chun, S. G., Shaeffer, D. S. & Bryant-Greenwood, P. K. The Werner\u2019s Syndrome RecQ helicase\/exonuclease at the nexus of cancer and aging. Hawaii Med. J. 70, 52\u201355 (2011).","journal-title":"Hawaii Med. J."},{"key":"BFjhg2013107_CR60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/nar\/gks1134","volume":"41","author":"V Popuri","year":"2013","unstructured":"Popuri, V., Huang, J., Ramamoorthy, M., Tadokoro, T., Croteau, D. L. & Bohr, V. A. RECQL5 plays co-operative and complementary roles with WRN syndrome helicase. Nucleic Acids Res. 41, 881\u2013899 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFjhg2013107_CR61","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","volume":"87","author":"D Chen","year":"2002","unstructured":"Chen, D., Misra, A. & Garg, A. Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J. Clin. Endocrinol. Metab. 87, 4845\u20134856 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2013107_CR62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181aa1308","volume":"51","author":"JC Shlay","year":"2009","unstructured":"Shlay, J. C., Sharma, S., Peng, G., Gibert, C. L. & Grunfeld, C., Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA); International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 51, 298\u2013304 (2009).","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"BFjhg2013107_CR63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e3282f33557","volume":"22","author":"RM Blumer","year":"2008","unstructured":"Blumer, R. M., van Vonderen, M. G., Sutinen, J., Hassink, E., Ackermans, M., van Agtmael, M. A. et al. Zidovudine\/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy. AIDS 22, 227\u2013236 (2008).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR64","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/01.aids.0000242815.80462.5a","volume":"20","author":"M Pacenti","year":"2006","unstructured":"Pacenti, M., Barzon, L., Favaretto, F., Fincati, K., Romano, S., Milan, G. et al. Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs. AIDS 20, 1691\u20131705 (2006).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","volume":"12","author":"C Lagathu","year":"2007","unstructured":"Lagathu, C., Eustace, B., Prot, M., Frantz, D., Gu, Y., Bastard, J. P. et al. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir. Ther. 12, 489\u2013500 (2007).","journal-title":"Antivir. Ther."},{"key":"BFjhg2013107_CR66","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","volume":"359","author":"JP Bastard","year":"2002","unstructured":"Bastard, J. P., Caron, M., Vidal, H., Jan, V., Auclair, M., Vigouroux, C. et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359, 1026\u20131031 (2002).","journal-title":"Lancet"},{"key":"BFjhg2013107_CR67","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","volume":"275","author":"H Murata","year":"2000","unstructured":"Murata, H., Hruz, P. W. & Mueckler, M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J. Biol. Chem. 275, 20251\u201320254 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFjhg2013107_CR68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/599986","volume":"200","author":"M Sievers","year":"2009","unstructured":"Sievers, M., Walker, U. A., Sevastianova, K., Setzer, B., W\u00e5gs\u00e4ter, D., Eriksson, P. et al. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. J. Infect. Dis. 200, 252\u2013262 (2009).","journal-title":"J. Infect. Dis."},{"key":"BFjhg2013107_CR69","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","volume":"286","author":"JA Johnson","year":"2004","unstructured":"Johnson, J. A., Albu, J. B., Engelson, E. S., Fried, S. K., Inada, Y., Ionescu, G. et al. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 286, E261\u2013E271 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFjhg2013107_CR70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","volume":"374","author":"SE Hudon","year":"2008","unstructured":"Hudon, S. E., Coffinier, C., Michaelis, S., Fong, L. G., Young, S. G. & Hrycyna, C. A. HIV-protease inhibitors block the enzymatic activity of purified Ste24p. Biochem. Biophys. Res. Commun 374, 365\u2013368 (2008).","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"BFjhg2013107_CR71","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1097\/QAD.0b013e328359b8be","volume":"26","author":"L Gibellini","year":"2012","unstructured":"Gibellini, L., De Biasi, S., Pinti, M., Nasi, M., Riccio, M., Carnevale, G. et al. The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes. AIDS 26, 2017\u20132026 (2012).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR72","doi-asserted-by":"crossref","first-page":"e59514","DOI":"10.1371\/journal.pone.0059514","volume":"8","author":"BS Zha","year":"2013","unstructured":"Zha, B. S., Wan, X., Zhang, X., Zha, W., Zhou, J., Wabitsch, M. et al. HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes. PLoS One 8, e59514 (2013).","journal-title":"PLoS One"},{"key":"BFjhg2013107_CR73","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr, A., Miller, J., Law, M. & Cooper, D. A. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14, F25\u2013F32 (2000).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR74","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","volume":"42","author":"H Lee","year":"2003","unstructured":"Lee, H., Hanes, J. & Johnson, K. A. Toxicity of nucleoside analogs used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 42, 14711\u201314719 (2003).","journal-title":"Biochemistry"},{"key":"BFjhg2013107_CR75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/em.20245","volume":"48","author":"RL Divi","year":"2007","unstructured":"Divi, R. L., Haverkos, K. J., Humsi, J. A., Shockley, M. E., Thamire, C., Nagashima, K. et al. Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ. Mol. Mutagen. 48, 179\u2013189 (2007).","journal-title":"Environ. Mol. Mutagen."},{"key":"BFjhg2013107_CR76","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/00365540903186181","volume":"41","author":"A Maagaard","year":"2009","unstructured":"Maagaard, A. & Kvale, D. Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity. Scand. J. Infect. Dis. 41, 808\u2013817 (2009).","journal-title":"Scand. J. Infect. Dis."},{"key":"BFjhg2013107_CR77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","volume":"23","author":"RH Haubrich","year":"2009","unstructured":"Haubrich, R. H., Riddler, S. A., DiRienzo, A. G., Komarow, L., Powderly, W. G., Klingman, K. et alAIDS Clinical Trials Group (ACTG) A5142 Study Team Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS 23, 1109\u20131118 (2009).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR78","doi-asserted-by":"crossref","first-page":"15130","DOI":"10.1074\/jbc.M312875200","volume":"279","author":"K El Hadri","year":"2004","unstructured":"El Hadri, K., Glorian, M., Monsempes, C., Dieudonn\u00e9, M. N., Pecquery, R., Giudicelli, Y. et al. In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes. J. Biol. Chem. 279, 15130\u201315141 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFjhg2013107_CR79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.23647","volume":"52","author":"A Blas-Garcia","year":"2010","unstructured":"Blas-Garcia, A., Apostolova, N., Ballesteros, D., Monle\u00f3n, D., Morales, J. M., Rocha, M. et al. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells. Hepatology 52, 115\u2013125 (2010).","journal-title":"Hepatology"},{"key":"BFjhg2013107_CR80","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/QAD.0b013e32830a9886","volume":"22","author":"K Ranade","year":"2008","unstructured":"Ranade, K., Geese, W. J., Noor, M., Flint, O., Tebas, P., Mulligan, K. et al. Genetic analysis implicates resistin in HIV lipodystrophy. AIDS 22, 1561\u20131568 (2008).","journal-title":"AIDS"},{"key":"BFjhg2013107_CR81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2796.2007.01854.x","volume":"262","author":"M Ryden","year":"2007","unstructured":"Ryden, M. & Arner, P. Tumour necrosis factor-alpha in human adipose tissue\u2014from signaling mechanisms to clinical implications. J. Intern. Med. 262, 431\u2013438 (2007).","journal-title":"J. Intern. Med."},{"key":"BFjhg2013107_CR82","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1152\/ajpendo.90224.2008","volume":"295","author":"K Sevastianova","year":"2008","unstructured":"Sevastianova, K., Sutinen, J., Kannisto, K., Hamsten, A., Ristola, M. & Yki-J\u00e4rvinen, H. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 295, E85\u2013E91 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFjhg2013107_CR83","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","volume":"51","author":"C Hadigan","year":"2002","unstructured":"Hadigan, C., Borgonha, S., Rabe, J., Young, V. & Grinspoon, S. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy. Metabolism 51, 1143\u20131147 (2002).","journal-title":"Metabolism"},{"key":"BFjhg2013107_CR84","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2009.09.018","volume":"1801","author":"F Villarroya","year":"2010","unstructured":"Villarroya, F., Domingo, P. & Giralt, M. Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment. Biochim. Biophys. Acta 1801, 392\u2013399 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFjhg2013107_CR85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/me.2007-0124","volume":"22","author":"S Shrivastav","year":"2008","unstructured":"Shrivastav, S., Kino, T., Cunningham, T., Ichijo, T., Schubert, U., Heinklein, P. et al. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy. Mol. Endocrinol. 22, 234\u2013247 (2008).","journal-title":"Mol. Endocrinol."},{"key":"BFjhg2013107_CR86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","volume":"108","author":"A Garg","year":"2000","unstructured":"Garg, A. Lipodystrophies. Am. J. Med. 108, 143\u2013152 (2000).","journal-title":"Am. J. Med."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg2013107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2013107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2013107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:28:16Z","timestamp":1688556496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg2013107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFjhg2013107"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2013.107","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]}}}